Fresenius Medical Care AG & Co. KGaA Stock Forecast for 2023 - 2025 - 2030
Updated on 05/07/2024
Fresenius Medical Care AG & Co. KGaA Stock Forecast and Price Target
Fresenius Medical Care AG & Co. KGaA's stock price reaches the average target of 38.50€ by 2025 as expected recently by twelve notable experts, there would be a potential downside of approximately -2.8% from the last closing price in May, 2024. This possible increase is based on a high estimate of 58.50€ and a low estimate of 26.00€. If you're thinking of investing in FME stock, it might be good to look at its rivals too.
-2.80% Downside
Fresenius Medical Care AG & Co. KGaA Fair Value Forecast for 2023 - 2025 - 2030
Fresenius Medical Care AG & Co. KGaA's Price has decreased by 100.00% In the last four years, from 70.22€ to 0.00€. For next year, analysts predict Fair Value of 44.38€, which would mean an increase of 100.00%. Over the next seven years, experts predict that Fresenius Medical Care AG & Co. KGaA's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
LLY Stock Forecast | Eli Lilly and | Outperform |
16
|
$766.68 | Buy/Sell | $636.99 | 14.78% |
JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$148.58 | Buy/Sell | $174.55 | 14.42% |
MRK Stock Forecast | Merck | Outperform |
2
|
$127.57 | Buy/Sell | $130.51 | 12.10% |
ABBV Stock Forecast | AbbVie | Outperform |
9
|
$162.73 | Buy/Sell | $178.42 | 13.69% |
AZN Stock Forecast | AstraZeneca PLC | Outperform |
17
|
£120.50 | Buy/Sell | £165.99 | 35.23% |
Fresenius Medical Care AG & Co. KGaA Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Fresenius Medical Care AG & Co. KGaA's Revenue has grown by 8.62%, rising from 17.86€B to 19.40€B. For next year, analysts predict Revenue of 20.19€B, which would mean an increase of 4.09%. Over the next seven years, experts predict that Fresenius Medical Care AG & Co. KGaA's Revenue will grow at a rate of 36.18%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
NOVN Stock Forecast | Novartis | Hold |
10
|
CHF88.10 | Buy/Sell | CHF105.00 | 22.16% |
ROG Stock Forecast | Roche Holding | Hold |
16
|
CHF218.50 | Buy/Sell | CHF307.83 | 24.71% |
DHR Stock Forecast | Danaher | Outperform |
10
|
$247.40 | Buy/Sell | $260.33 | 10.12% |
Fresenius Medical Care AG & Co. KGaA Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Fresenius Medical Care AG & Co. KGaA's Dividend per Share has decreased from 1.34€ to 1.12€ – a 16.42% drop! For next year, analysts predict Dividend per Share of 1.15€, which would mean an increase of 2.68%. Over the next seven years, experts predict that Fresenius Medical Care AG & Co. KGaA's Dividend per Share will grow at a rate of 83.93%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
GE Stock Forecast | General Electric | Buy |
8
|
$167.97 | Buy/Sell | $144.00 | 7.17% |
AMGN Stock Forecast | Amgen | Outperform |
4
|
$299.48 | Buy/Sell | $303.65 | 6.85% |
PFE Stock Forecast | Pfizer | Outperform |
2
|
$28.16 | Buy/Sell | $32.87 | 8.31% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$325.50 | Buy/Sell | $353.16 | 15.51% |
SAN Stock Forecast | Sanofi | Outperform |
16
|
91.02€ | Buy/Sell | 102.80€ | 19.75% |
BSX Stock Forecast | Boston Scientific | Buy |
11
|
$72.55 | Buy/Sell | $70.14 | 13.03% |
Fresenius Medical Care AG & Co. KGaA EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Fresenius Medical Care AG & Co. KGaA's EBITDA has decreased by 21.93%, from 3.19€B to 2.49€B. In the next year, analysts believe that EBITDA will reach 3.49€B – an increase of 40.31%. For the next seven years, experts predict that Fresenius Medical Care AG & Co. KGaA's EBITDA will grow at a rate of 105.11%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BMY Stock Forecast | Bristol-Myers Squibb | Hold |
2
|
$43.90 | Buy/Sell | $58.15 | 23.01% |
GSK Stock Forecast | GSK | Outperform |
12
|
£17.34 | Buy/Sell | £17.30 | 12.46% |
6501 Stock Forecast | Hitachi | Outperform |
4
|
¥14.46k | Buy/Sell | ¥11.29k | 10.69% |
Fresenius Medical Care AG & Co. KGaA EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Fresenius Medical Care AG & Co. KGaA's EBIT has fallen from 2.35€B to 1.58€B – a 32.85% decrease. In the next year, analysts believe that EBIT will reach 1.77€B – an increase of 12.19%. For the next seven years, the forecast is for EBIT to grow by 112.02%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MRK Stock Forecast | Merck KGaA | Outperform |
18
|
151.95€ | Buy/Sell | 190.06€ | 17.14% |
BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$236.58 | Buy/Sell | $284.47 | 17.30% |
4502 Stock Forecast | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.13k | Buy/Sell | ¥4.74k | 10.30% |
Fresenius Medical Care AG & Co. KGaA EPS Price Prediction Forecast for 2023 - 2025 - 2030
Fresenius Medical Care AG & Co. KGaA's EPS has decreased by 100.00% In the last four years, from 4.62€ to 0.00€. For next year, analysts predict EPS of 2.92€, which would mean an increase of 100.00%. Over the next seven years, experts predict that Fresenius Medical Care AG & Co. KGaA's EPS will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BIIB Stock Forecast | Biogen | Outperform |
10
|
$221.42 | Buy/Sell | $299.62 | 30.30% |
CERN Stock Forecast | Cerner | - |
13
|
$94.92 | Buy/Sell | $95.00 | -63.34% |
SIEMENS Stock Forecast | Siemens | Outperform |
16
|
Rp6.11k | Buy/Sell | Rp4.02k | -19.77% |